TAXES 2,211,265 970,025 6,808,625 3,567,857
NET INCOME 4,474,833 1,876,573 12,863,288 7,405,372
OTHER COMPREHENSIVE
INCOME:
Unrealized (loss)
gain on marketable
securities (270,351) -- 1,347,852
Foreign currency
translation
adjustment 1,960,948 368,537 3,428,779 673,047
COMPREHENSIVE INCOME $6,165,430 $2,245,110 $17,639,919 $8,078,419
WEIGITED AVERAGE
NUMBER OF SHARES:
Basic 389,605,134 84,545,655 260,297,377 84,131,121
Diluted 393,292,698 90,950,796 263,271,624 89,658,922
EARNINGS PER SHARE:
Basic $0.01 $0.02 $0.05 $0.09
Diluted $0.01 $0.02 $0.05 $0.08
GENESIS PHARMACEUTICALS ENTERPRISES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
AS OF MARCH 31, 2008
A S S E T S
(Unaudited)
CURRENT ASSETS:
Cash $21,574,044
Restricted cash 3,488,604
Marketable equity securities 2,112,500
Accounts receivable, net of
allowance for doubtful accounts of
$62,625 20,589,289
Accounts receivable - related
parties 2,019,278
Inventories 5,542,846
Other receivables 284,908
Other receivables - related parties
'/>"/>
| SOURCE Genesis Pharmaceuticals Enterprises, Inc. Copyright©2008 PR Newswire. All rights reserved |